An Rx for Drug Prices: D.C. should drop the rhetoric and pass this one reform

Image content: This image is available to view online.

View image online (https://assets.clevelandclinic.org/transform/0704c34e-3185-433b-b3e7-5c3cef844cf9/Knoer-headshot-14_jpg)

Scott Knoer, M.S., Pharm.D., Chief Pharmacy Officer

Politicians on all sides have talked about the need for drug price reform. Yet, despite the rhetoric, not a single federal law related to drug prices has passed.

It’s time to move past the empty promises and generate tangible results, Cleveland Clinic Pharmacy Officer Scott Knoer argues in a Newsweek op-ed.

While there are many potential solutions to the drug price problem, let’s focus on just one simple approach that is proven to be effective – increase competition in the marketplace by:

• Passing the CREATES Act, which would allow generic versions of drugs to get to market faster after the patent protection ends.
• Speeding up the approval and use of gneric and biosimilar drugs.

Read the entire piece at Newsweek.com: HOW TO REDUCE MEDICAL DRUG PRICES AT A STROKE